Dual-acting compounds that deliver an acidifying domain via zanamivir to the virus surface are potent influenza inhibitors
Science Advances · 06.11.2026 · 12 (45)
DOI: 10.1126/sciadv.aei8633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von Charley Mackenzie-Kludas und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Aust…. Hauptthemen laut MEDLINE: Antiviral Agents, Zanamivir, Orthomyxoviridae, Influenza, Human. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council of Australia, Aus Bio Pty Ltd.
Abstract (Originalsprache)
While contemporary antiviral development primarily strives to produce “lock and key” inhibitors, we present here a different approach to drug design that uses compounds devised to alter the microenvironment of the virion surface, making it incompatible with virus entry. We illustrate this strategy with inhibitors of influenza virus and show that compounds designed to produce a proton-rich mantle above the virion surface affect the ability of the viral hemagglutinin to interact with cellular receptors and gain entry to the cell. The compounds show exceptional antiviral activity both in vitro and in vivo and protect against influenza illness in ferrets and in mice after a single dose, either therapeutically or prophylactically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
- AusBio Ltd., Melbourne, Australia.
- The World Health Organisation Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
- International Collaboration Unit, International Institute for Zoonosis Control, and the Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.
ORCID-Profile: Charley Mackenzie-Kludas, Wen-Yang Wu, Jennifer L McKimm-Breschkin, Celeste M K Tai, Lorena E Brown
Förderung
- National Health and Medical Research Council of Australia
- Aus Bio Pty Ltd
Zitieren
APA
Mackenzie-Kludas, C., Wu, W. Y., Jin, B., McKimm-Breschkin, J. L., Seah, E. L., Jones, P., Fairmaid, E., Tai, C. M. K., Oh, D. Y., Jenkins, P. J., Hurt, A. C., & Brown, L. E. (2026). Dual-acting compounds that deliver an acidifying domain via zanamivir to the virus surface are potent influenza inhibitors. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aei8633
Vancouver
Mackenzie-Kludas C, Wu WY, Jin B, McKimm-Breschkin JL, Seah EL, Jones P, et al. Dual-acting compounds that deliver an acidifying domain via zanamivir to the virus surface are potent influenza inhibitors. Science Advances. 2026;12(45). doi:10.1126/sciadv.aei8633
BibTeX
@article{MackenzieKludas2026,
author = {Mackenzie-Kludas, Charley and Wu, Wen-Yang and Jin, Betty and McKimm-Breschkin, Jennifer L and Seah, Ee Ling and Jones, Paul and Fairmaid, Emily and Tai, Celeste M K and Oh, Ding Yuan and Jenkins, Peter J and Hurt, Aeron C and Brown, Lorena E},
title = {Dual-acting compounds that deliver an acidifying domain via zanamivir to the virus surface are potent influenza inhibitors},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {45},
doi = {10.1126/sciadv.aei8633}
}
EUVIMED